CFG
XGN icon

Citizens Financial Group’s Exagen XGN Stock Holding History

Citizens Financial Group’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-54,620
Closed -$332K – 925
2025
Q4 		$332K Sell
54,620
-2,900
-5% -$26.4K ﹤0.01% 635
2025
Q3 		$632K Sell
57,520
-10,080
-15% -$89.3K 0.01% 492
2025
Q2 		$472K Buy
+67,600
New +$411K 0.01% 485

Other funds holding XGN

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return

Citizens Financial Group's XGN Position: Q1 2026 in Review

Citizens Financial Group sold out of Exagen (XGN) in Q1 2026, closing a stake of 54,620 shares — an estimated $332K sold.

Citizens Financial Group first reported a position in XGN in Q2 2025 and held it in 3 quarters. The position peaked at $632K in Q3 2025. 61 funds tracked by Wall St. Rank hold XGN as of Q1 2026.

  • Citizens Financial Group reported no remaining Exagen position as of Q1 2026 after selling out during the quarter.
  • Citizens Financial Group sold 54,620 Exagen shares in Q1 2026, an estimated $332K.
  • Citizens Financial Group first reported a position in Exagen in Q2 2025 and held it in 3 quarters.
  • Citizens Financial Group's Exagen position peaked at $632K in Q3 2025.
  • 61 funds tracked by Wall St. Rank held Exagen as of Q1 2026.

Based on Citizens Financial Group's 13F filing for Q1 2026, filed 1 May 2026.